BioSpace News Archive

Dr. Gary Donovitz, Founder and Chairman of BioTE Medical, says that the future of millions of otherwise healthy women could be in jeopardy if the recent position statement published in the October issue of The Journal of Clinical Endocrinology & Metabolism is given any credence.

Findings Indicate Safety, Tolerability and Proof of Mechanism in Healthy Volunteers, Support the Potential of FT-4202 to Beneficially Impact Hemoglobin Levels and Vaso-occlusive Crises

Akers Biosciences, Inc. announced the closing of its previously announced public offering of 613,500 common units at a public offering price of $4.00 per unit and 1,376,500 pre-funded units at a public offering price of $3.9999 per pre-funded unit, raising gross proceeds of $7.96 million, before deducting placement agent’s fees and other estimated offering expenses payable by Akers, assuming none of the preferred stock warrants issued in this offering are exercised.

HelixBind, Inc. announced the expansion of its funding and support from CARB-X,, a global partnership funding the development of promising new antibacterial treatment, prevention and diagnostic products.

CPS’ PAInS Program Designed to Help Reduce Opioid Use Through Pharmacist Continuing Education

Preclinical data support the development of KB-3061 as a potential precision medicine treatment for a rare pediatric epilepsy

Stadius Biopharma LLC will present data on its fully human antibodies to Candida at the upcoming Antibody Engineering & Therapeutics meeting December 9 – 13, 2019 in San Diego.

The two organizations have finalized their 2020 plans and selected leadership for their powerful, new partnership to advance ophthalmic innovation

Infiniti Research, a leading market intelligence solutions provider, has recently announced the completion of its latest success story on market intelligence solution.

Room temperature stable Vancomycin injection premix dose of 500 mg in 100 mL ready-to-use bag is now available for purchase in the US